We provide you with 20 years of free, institutional-grade data for APM stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of APM. Explore the full financial landscape of APM stock.
| Reported Date | CIK | Ticker | Type |
|---|
Aptorum Group Ltd.(NASDAQ:APM) 
Aptorum Group Ltd. is a pharmaceutical company, which engages in the development and commercialization of therapeutic and diagnostic technologies. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop various drug molecules and certain technolo...
Website: http://www.aptorumgroup.com
Founded: 2010
Full Time Employees: 41
CEO: Ian Huen
Sector: Health Technology
Industry: Pharmaceuticals: Major
The information provided in this report about APM stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.